The full team came up on live cast today , they all sounded over excited , The chirma , The CEO , the CMO
By end of Q2 2014 , they will be havng under development ,
+ 4 orphan diseases
+ 2 GSO targeted diseases
What can we expect more , this company is very well resourced in science , and with the addition of the BAKER's on the Board , I think it will add to the confidence of going really to umet levels
CONGRATULATIONS to all LONG
Company has made amazing progress in last 6 months. Traders here trying to create every single opportunity to get back in by posting panic messages using new IDs.
As per Sudhir, they will still add new people to the team. I am very happy to see the long term picture here.
Mgmt gave us all a "wink and a nod" today with the orphan indication announcement. As someone mentioned, do you think they'd be going ahead if they did not feel confident in "proof of concept" results?
100%!! Great CC. The addition of the higher dosing level was procedural since they had positive safety data from lower doses. This is a dream team of scientists and experienced biotech veterans whom recognize the blockbuster potential with IDRA.
Ignore noise and take advantage of MM's games! Buy all dips....if you're lucky enough to get one.